In the news: The European Medicines Agency

2866066390_0fbbabe7c1_m
© Rodrigo Senna and licensed for reuse under this Creative Commons Licence.

Yesterday it was announced that the European Medicines Agency will relocate from London to Amsterdam.  The EMA is an agency of the European Union and its role involves the scientific evaluation, supervision and safety monitoring of medicines for human and animal use as well as assisting national agencies authorise medicine sales within the EU single market.

The EMA has to relocate due to the UK decision to leave the EU and the UK Government’s desire to no longer be subject to the jurisdiction of the European Court of Justice.

EMA has been based in London, UK,  since it’s location was secured by John Major’s government in 1995, the year the Agency was established. It currently employs nearly 900 people with a further 36,000 scientists and regulators visiting each year.

A House of Commons Library Research Paper entitled Brexit and medicines regulation looks at how medicines are currently regulated in the UK, the role of the EMA and what the options are post Brexit.

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.